On September 13 2023, Honorable Dr. Asim Rauf, the Chief Executive Officer of The Drug Regulatory Authority of Pakistan, joined by Dr. Saif Ur Rehman Khattak (Director CDL/FGA), Mr. Abdul Mughees Mudassir (Asst. Diretor to CEO), and Mr. Waqas Ahmed (Chief of Party/Country Director, USP) inaugrated a world-class contract analytical laboratory in Karachi. This laboratory, previously located in Islamabad and achieved WHO Prequalification status on April 17,2020 under the ownership of Prime Health Pvt. Limited. It provides servies globally.
IBL Group has acquired Prime Health Pvt. Limited, including the laboratory, and is committed to maintaining and expanding similar services in the furture. IBL is a diversified business conglomerate engaged in various sectors, including Distribution, Sales, Manufacuring, Marketing, Retail and information Technology.
IBL Group has acquired Prime Health Pvt. Limited, including the laboratory, and is committed to maintaining and expanding similar services in the furture. IBL is a diversified business conglomerate engaged in various sectors, including Distribution, Sales, Manufacuring, Marketing, Retail and information Technology.